Partner with us
We鈥檙e committed to building sustainable relationships across the scientific and business communities that help us combine transformative advances in the understanding of human disease with the science of therapeutics, all with the goal of advancing human health.

We鈥檙e committed to building sustainable relationships across the scientific and business communities that help us combine transformative advances in the understanding of human disease with the science of therapeutics, all with the goal of advancing human health.
Collaboration defines our culture
We know that collaborating with the world鈥檚 experts is a cornerstone to solving some of science鈥檚 most difficult problems. Collaboration is one of our core values at Vertex: We want the best and brightest minds from all backgrounds around the table solving tough problems.

Externally, our collaborations with companies, academia, research organizations and nonprofit organizations help drive scientific innovation and the development of new medicines.

Internally, we strive to create a collaborative environment that encourages the open exchange of ideas and provides the freedom for our talented employees to explore new scientific concepts.
Partnerships enhance scientific innovation
To support our mission, we seek external partnerships that promote scientific innovation. We believe that innovation should not be limited to opportunities based on specific stages of development or particular treatment modalities, but instead, focused on creating relationships that are grounded in deep biological knowledge of the disease and target. Our sense of urgency for patients drives us to seek the best of the best, inside and outside of Vertex鈥檚 walls, to achieve our goals as fast as possible.

Our current priorities include:
-
Supporting Vertex鈥檚 R&D strategy of bringing innovative medicines to patients by complementing our existing research efforts and clinical assets with additional tools and/or technologies.
-
Diversifying our portfolio with potentially transformative medicines for diseases where there is a high unmet need.
-
Leveraging cutting-edge technology platforms to accelerate the discovery of new disease targets, compounds, delivery mechanisms and potential treatment modalities.
-
Maximizing the potential of Vertex programs by using strategic collaborations and licensing opportunities to enable speedy and thorough development.
Vertex is a trusted partner

We value developing strategic relationships that are mutually beneficial. Our approach is to create successful partnerships with well-articulated principles and value propositions. Our portfolio of alliances consists of a variety of collaboration models to meet the different needs of our partners.
Vertex works to maximize the value of our partnerships, seeking to make decisions that align our common goals and, most importantly, bring benefits to patients as quickly as possible. We work collaboratively to make informed and strategic decisions to rapidly progress our partnered programs.
Areas of interest
We're actively exploring all approaches that may change the treatment of a serious disease where no adequate treatment currently exists. We are seeking technologies that will enable exploration of new diseases or disease targets.
Please also contact us if you'd like to explore a potential partnership related to any of the following:
Our global network of innovation
External collaborations expand our drug discovery toolbox and further our commitment to transforming serious diseases. We have partnerships in cell and genetic therapies, innovation in small molecule and intracellular therapeutics, targets and human cell models, and other areas. Learn more about our current partnerships below.

CRISPR Therapeutics
announcement
announcement

Entrada Therapeutics
announcement

Genomics plc
announcement

ImmunoGen
announcement

Mammoth Biosciences
announcement

Moderna
announcement
announcement

Orna Therapeutics
announcement

Orum Therapeutics
announcement

Ribometrix
announcement

Stablix
announcement

TreeFrog Therapeutics
announcement

X-Chem
announcement

Zai Lab
announcement